Latanoprostene bunod (LBN) 0.024% reduced intraocular pressure (IOP) more than latanoprost 0.005% (Xalatan, Pfizer), but with more side effects, in a study of patients with open angle glaucoma (OAG) or ocular hypertension (OHT).
Reuters Health Information